Cognitive deficits, obesity and disability in schizophrenia

Translational Neuroscience

Volumn 3, Issue 4, 2012, Pages 345-354

  Strassnig, Martin T ^a   Caceda, Ricardo ^a   Newcomer, John W ^a   Harvey, Philip D ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cognition; Functional capacity; Novel treatments; Obesity; Schizophrenia

Indexed keywords

GLUCOSE; INSULIN; LIPID; NEUROLEPTIC AGENT;

ADL DISABILITY; BRAIN DAMAGE; BRAIN FUNCTION; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; COGNITIVE REMEDIATION THERAPY; COGNITIVE THERAPY; COMORBIDITY; DAILY LIFE ACTIVITY; DECISION MAKING; DYSLIPIDEMIA; FOOD COMPOSITION; FOOD PREFERENCE; HEALTH BEHAVIOR; HEALTH STATUS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; MEMORY DISORDER; METABOLIC SYNDROME X; NEUROBIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COMPLIANCE; PATIENT MONITORING; PHYSICAL ACTIVITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; SCHIZOPHRENIA; SEDATION; SEDENTARY LIFESTYLE; SELF CARE; SIDE EFFECT; SOCIAL DISABILITY; VERBAL MEMORY; WEIGHT CONTROL; WORK DISABILITY; WORKING MEMORY;

EID: 84871425786     PISSN: 20813856     EISSN: 20816936     Source Type: Journal    
DOI: 10.2478/s13380-012-0046-5     Document Type: Review

References (101)

1. Green M.F., Kern R.S., Braff D.L., Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?, Schizophr. Bull., 2000, 26, 119-136 (Pubitemid 30317696)
2. Green M.F., Cognitive impairment and functional outcome in schizophrenia and bipolar disorder, J. Clin. Psychiatry, 2006, 67 (Suppl. 9), 3-8, discussion 36-42 (Pubitemid 44369648)
3. Bowie C.R., Depp C., McGrath J.A., Wolyniec P., Mausbach B.T., Thornquist M.H., et al., Prediction of real world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder, Am. J. Psychiatry, 2010, 167, 1116-1124
4. Bowie, C.R., Leung, W.W., Reichenberg, A., McClure, M.M., Patterson, L., Heaton, R.K., Harvey, P.D., Predicting schizophrenia patients' real world behavior with specific neuropsychological and functional capacity measures, Biol. Psychiatry, 2008, 63, 505-511 (Pubitemid 351220787)
5. Caspi A., Reichenberg A., Weiser M., Rabinowitz J., Kaplan Z., Knobler H., et al., Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode, Schizophr. Res., 2003, 65, 87-94 (Pubitemid 37434015)
6. Bowie C.R., Harvey P.D., Cognition in schizophrenia: impairments, determinants, and functional importance, Psychiatr. Clin. North Am., 2005, 28, 613-633 (Pubitemid 41191137)
7. Harvey P.D., Velligan D.I., Bellack A.S., Performance-based measures of functional skills: usefulness in clinical treatment studies, Schizophr. Bull., 2007, 33, 1138-1148 (Pubitemid 47347915)
8. Bowie C.R., McGurk S.R., Mausbach B., Patterson T.L., Harvey P.D., Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior, Am. J. Psychiatry, 2012, doi:10.1176/appi. ajp.2012.11091337 [Epub ahead of print]
9. Harvey P.D., Cognitive impairment in schizophrenia: profile, course, and neurobiological determinants, Handb. Clin. Neurol., 2012, 106, 433-445
10. Vinogradov S., Fisher M., de Villers-Sidani E., Cognitive training for impaired neural systems in neuropsychiatric illness, Neuropsychopharmacology, 2012, 37, 43-76
11. Harvey P.D., Strassnig M., Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status, World Psychiatry, 2012, 11, 73-79
12. Murray C.L., Lopez A.D., Global mortality, disability, and the contributions of risk factors: global burden of disease study, Lancet, 1997, 349, 1436-1442 (Pubitemid 27212192)
13. US Dept of Health and Human Services, Physical activity and health: a report of the surgeon general, Atlanta (GA), US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996
14. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E., Schizophrenia and increased risks of cardiovascular disease, Am. Heart J., 2005, 150, 1115-1121 (Pubitemid 41773510)
15. McEvoy J.P., Meyer J.M., Goff D.C., Nasrallah H.A., Davis S.M., Sullivan L., et al., Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III, Schizophr. Res., 2005, 80, 19-32 (Pubitemid 41587460)
16. Jin H., Folsom D., Sasaki A., Mudaliar S., Henry R., Torres M., et al., Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms, Schizophr. Res., 2011, 125, 295-299
17. Newcomer J.W., Metabolic risk during antipsychotic treatment, Clin. Therapeutics, 2004, 26, 1936-1946 (Pubitemid 40353605)
18. Maayan L., Correll C.U., Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents, J. Child Adolesc. Psychopharmacol., 2011, 21, 517-535
19. Casey D.E., Haupt D.W., Newcomer J.W., Henderson D.C., Sernyak M.J., Davidson M., et al., Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J. Clin. Psychiatry, 2004, 65 (Suppl. 7), 4-18
20. Newcomer J.W., Metabolic syndrome and mental illness. Am. J. Manag. Care, 2007, 13 (Suppl. 7), S170-177 (Pubitemid 350231678)
21. Newcomer J., Hennekens C.H., Severe mental illness and risk of cardiovascular disease, JAMA, 2007, 298, 1794-1796 (Pubitemid 47598448)
22. Druss B.G., Newcomer J.W., Challenges and solutions to integrating mental and physical health care, J. Clin. Psychiatry, 2007, 68, e09
23. Morrato E.H., Druss B., Hartung D.M., Valuck R.J., Allen R., Campagna E., et al., Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs, Arch. Gen. Psychiatry 2010, 67, 17-24
24. Brown S., Birtwistle J., Roe L., Thompson C., The unhealthy lifestyle of people with schizophrenia, Psychol. Med., 1999, 29, 697-701 (Pubitemid 29261358)
25. Strassnig M., Brar J.S., Ganguli R., Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia, Schizophr. Res., 2006, 86, 269-275 (Pubitemid 44234052)
26. Strassnig M., Brar J.S., Ganguli R., Nutritional assessment of patients with schizophrenia: a preliminary study, Schizophr. Bull., 2003, 29, 393-397 (Pubitemid 37187700)
27. Newcomer J.W. Metabolic risk during antipsychotic treatment. Clin. Ther., 2004, 26, 1936-1946 (Pubitemid 40353605)
28. Patterson R.E., Haines P.S., Poplin B.M., Diet quality index: capturing a multidimensional behavior, J. Am. Diet. Assoc., 1994, 94, 57-64 (Pubitemid 24042186)
29. Strassnig M., Singh Brar J., Ganguli R., Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia, Schizophr. Res., 2005, 76, 343-351 (Pubitemid 40804781)
30. McCreadie R., Macdonald E., Blacklock C., Tilak-Singh D., Wiles D., Halliday J., et al., Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study, BMJ, 1998, 317, 784-785 (Pubitemid 28427229)
31. McCrory M.A., Fuss P.J., McCallum J.E., Yao M., Vinken A.G., Hays N.P., et al., Dietary variety within food groups: association with energy intake and body fatness in adult men and women, Am. J. Clin. Nutr., 1999, 69, 440-447 (Pubitemid 29104564)
32. Drewnowski A., Energy density, palatability, and satiety: implications for weight control, Nutr. Rev., 1998, 56, 347-353 (Pubitemid 29023050)
33. Strassnig M., Brar J.S., Ganguli R., Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia, Schizophr. Res., 2011, 126, 103-109
34. Ganguli R., Strassnig M., Prevention of metabolic syndrome in serious mental illness, Psychiatr. Clin. North. Am., 2011, 34, 109-125
35. Strassnig M., Brar J.S., Ganguli R., Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia, Schizophr. Res., 2005, 15, 75, 425-432 (Pubitemid 40693073)
36. Vancampfort D., Probst M., Knapen J., Carraro A., De Hert M., Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia, Psychiatry Res., 2012 [Epub ahead of print]
37. Chwastiak L.A., Rosenheck R.A., Kazis L.E., Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans, Psychosomatics, 2011, 52, 230-236
38. Strassnig M., Brar J.S., Ganguli R., Health-related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: preliminary study, Diabetes Metab. Syndr. Obes., 2012, 5, 389-394
39. Bowie C.R., Reichenberg A., Patterson T.L., Heaton R.K., Harvey P.D., Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms, Am. J. Psychiatry, 2006, 163, 418-425 (Pubitemid 44469383)
40. Gupta M., Bassett E., Iftene F., Bowie C.R., Functional outcomes in schizophrenia: understanding the competence-performance discrepancy, J. Psychiatr. Res., 2012, 46, 205-211
41. Kelleher I., Murtagh A., Clarke M.C., Murphy J., Rawdon C., Cannon M., Neurocognitive performance of a community-based sample of young people at putative ultra high risk for psychosis: Support for the processing speed hypothesis, Cogn. Neuropsychiatry., 2012, [Epub ahead of print]
42. Patterson T.L., Goldman S., McKibbin C.L., Hughs T., Jeste D.V., UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults, Schizophr. Bull., 2001, 27, 235-245 (Pubitemid 33644299)
43. Semkovska M., Bédard M.A., Godbout L., Limoge F., Stip E., Assessment of executive dysfunction during activities of daily living in schizophrenia, Schizophr. Res., 2004, 69, 289-300 (Pubitemid 38721426)
44. Keefe R.S., Vinogradov S., Medalia A., Silverstein S.M., Bell M.D., Dickinson D., et al., Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia, Schizophr. Bull., 2011, 37, 1057-1065
45. Levitt J.J., Bobrow L., Lucia D., Srinivasan P., A selective review of volumetric and morphometric imaging in schizophrenia, Curr. Top. Behav. Neurosci, 2010, 4, 243-281
46. Dowd E.C., Barch D.M., Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia, PLoS One, 2012, 7, e35622
47. Padrão G., Mallorquí A., Cucurell D., Marco-Pallares J., Rodriguez- Fornells A., Neurophysiological differences in reward processing in anhedonics, Cogn. Affect. Behav. Neurosci., 2012 [Epub ahead of print]
48. Ahn WY., Rass O., Fridberg D.J., Bishara A.J., Forsyth J.K., Breier A., et al. Temporal discounting and rewards in patients with bipolar disorder and schizophrenia, J. Abnorm. Psychology, 2011, 120, 911-921
49. Folley B.S., Park S., Relative food preference and hedonic judgments in schizophrenia, Psychiatry Res., 2010, 175, 33-37
50. Heerey E.A., Robinson B.M., McMahon R.P., Gold J.M., Delay discounting in schizophrenia, Cogn. Neuropsychiatry, 2007, 12, 213-221 (Pubitemid 46598194)
51. Kranz G.S., Kasper S., Lanzenberger R., Reward and the serotonergic system, Neuroscience, 2010, 166, 1023-1035
52. Berridge K.C., Kringelbach M.L., Affective neuroscience of pleasure: reward in humans and animals, Psychopharmacology, 2008, 199, 457-480
53. Der-Avakian A., Markou A., The neurobiology of anhedonia and other reward-related deficits, Trends Neurosci., 2012, 35, 68-77
54. Elman I., Borsook D., Lukas S.E., Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents, Neuropsychopharmacology, 2006, 31, 2091-2120 (Pubitemid 44413188)
55. Ng J., Stice E., Yokum S., Bohon C., An fMRI study of obesity, food reward, and perceived caloric density. Does a low-fat label make food less appealing?, Appetite, 2011, 57, 65-72
56. Wang G.J., Volkow N.D., Thanos P.K., Fowler J.S., Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review, J. Addict. Dis., 23, 39-53
57. Grimm O., Vollstaedt-Klein S., Krebs L., Zink M., Smolka M.N., Reduced striatal activation during reward anticipation due to appetiteprovoking cues in chronic schizophrenia: fMRI study, Schizophr. Res., 2012, 134, 151-157
58. McCreadie R.G., Kelly C., Connolly M., Williams S., Baxter G., Lean M., et al., Dietary improvement in people with schizophrenia: randomised controlled trial, Br. J. Psychiatry, 2005, 187, 346-351 (Pubitemid 41442387)
59. Heerley E.A., Bell-Warren K.R., Gold J.M., Decision-making impairments in the context of intact reward sensitivity in schizophrenia, Biol. Psychiatry, 2008, 64, 62-69
60. Knolle-Veentjer S., Huth V., Ferstl R., Aldenhoff J.B., Hinze-Selch D., Delay of gratification and executive performance in individuals with schizophrenia: putative role for eating behavior and body weight regulation, J. Psychiatr. Res., 2008, 42, 98-105 (Pubitemid 350061253)
61. Elman I., Borsook D., Lukas S.E., Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents, Neuropsychopharmacology, 2006, 31, 2091-2120 (Pubitemid 44413188)
62. Boeka A.G., Lokken K.L., Neuropsychological performance of a clinical sample of extremely obese individuals, Arch. Clin. Neuropsychol., 2008, 23, 467-474
63. Willeumier K.C., Taylor D.V., Amen D.G., Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults, Obesity, 2011, 19, 1095-1097
64. Brogan A., Hevey D., O'Callaghan G., Yoder R., O'Shea D., Impaired decision making among morbidly obese adults, J. Psychosom. Res., 2011, 70, 189-196
65. Beeri M.S., Ravona-Springer R., Silverman J.M., Haroutunian V., The effects of cardiovascular risk factors on cognitive compromise, Dialogues Clin. Neurosci., 2009, 11, 201-212
66. Panza F., Frisardi V., Capurso C., Imbimbo B.P., Vendemiale G., Santamato A., et al., Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms, J. Alzheimers Dis., 2010, 21, 691-724
67. McCrimmon R.J., Ryan C.M., Frier B.M., Diabetes and cognitive dysfunction, Lancet, 2012, 379, 2291-2299
68. Novak V., Hajjar I., The relationship between blood pressure and cognitive function, Nat. Rev. Cardiol., 2010, 7, 686-698
69. Willeumier K.C., Taylor D.V., Amen D.G., Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults, Obesity, 2011, 19, 1095-1097
70. Pannacciulli N., Del Parigi A., Chen K., Le D.S., Reiman E.M., Tataranni P.A., Brain abnormalities in human obesity: a voxel-based morphometric study, Neuroimage, 2006, 31, 1419-1425 (Pubitemid 43949229)
71. Walther K., Birdsill A.C., Gilsky E.L., Ryan L., Structural brain differences and cognitive functioning related to body mass index in older females, Hum. Brain. Mapp., 2010, 31, 1052-1064
72. Volkow N.D., Wang G-J., Telang F., Fowler J.S., Goldstein R.Z., Alia-Klein N., et al., Inverse association between BMI and prefrontal metabolic activity in healthy adults, Obesity, 2008, 17, 60-65 (Pubitemid 50310542)
73. Mozley L.H., Gur, R.H., Mozley P.D., Gur R.E., Striatal dopamine transporters and cognitive functioning in healthy men and women, Am. J. Psychiatry, 2001, 158, 1492-1499 (Pubitemid 32847251)
74. Volkow N.D., Logan J., Fowler J.S., Wang G.J., Gur R.C., Wong C., et al., Association between age-related decline in brain dompaine activity and impairment in frontal and cingulate metabolism, Am. J. Psychiatry, 2000, 157, 75-80 (Pubitemid 30027424)
75. Volkow N.D., Gur R.C., Wang G.J., Fowler J.S., Moberg P.J., Ding Y.S., et al., Association between decline in train dopamine activity with age and cognitive and motor impairment in healthy individuals, Am. J. Psychiatry, 1998, 155, 344-349 (Pubitemid 28114890)
76. Mozley L.H., Gur, R.H., Mozley P.D., Gur R.E., Striatal dopamine transporters and cognitive functioning in healthy men and women, Am. J. Psychiatry, 2001, 158, 1492-1499 (Pubitemid 32847251)
77. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Thanos P.K., Logan J., et al., Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible e contributing factors, Neuroimage, 2008, 42, 1537-1543
78. Kanoski S.E., Cognitive and neuronal systems underlying obesity, Physiol. Behav, 2012, 106, 337-344
79. McCrimmon R.J., Ryan C.M., Frier B.M., Diabetes and cognitive dysfunction, Lancet, 2012, 379, 2291-2299
80. Biessels G.J., Gispen W.H., The impact of diabetes on cognition: what can be learned from rodent models?, Neurobiol. Aging, 2005, 26 (Suppl. 1), 36-41
81. Fotuhi M., Do D., Jack C., Modifiable factors that alter the size of the hippocampus with ageing, Nat. Rev. Neurol., 2012, 8, 189-202
82. Nehlig A., Cerebral energy metabolism, glucose transport and blood flow: changes with maturation and adaptation to hypoglycaemia, Diabetes Metab., 1997, 23, 18-29 (Pubitemid 27099753)
83. McNay E.C., Recknagel A.K., Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes, Neurobiol. Learn. Mem., 2011, 96, 432-442
84. van den Berg E., Kloppenborg R.P., Kessels R.P., Kappelle L.J., Biessels G.J., Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition, Biochem. Biophys. Acta, 2009, 1792, 470-481
85. Friedman J.I., Wallenstein S., Moshier E., Parrella M., White L., Bowler S., et al., The effects of hypertension and body mass index on cognition in schizophrenia. Am. J. Psychiatry, 2010, 167, 1232-1239
86. Dickinson D., Gold J.M., Dickerson F.B., Medoff D., Dixon L.B., Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes, Psychosomatics, 2008, 49, 123-131 (Pubitemid 351364986)
87. National Heart, Lung and Blood Institute, National Institutes of Health, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report, National Institutes of Health, Bethesda (MD),1998, Publication 98-4083
88. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al., Diabetes Prevention Program Research Group, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N. Engl. J. Med., 2002, 346, 393-403 (Pubitemid 34437694)
89. Look AHEAD Research Group, Wing R.R., Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial, Arch. Intern. Med., 2010, 170, 1566-1575
90. Marks B.L., Katz L.M., Styner M., Smith J.K., Aerobic fitness and obesity: relationship to cerebral white matter integrity in the brain of active and sedentary older adults, Br. J. Sports Med., 2011, 45, 1208-1215
91. van den Berg E., Kloppenborg R.P., Kessels R.P., Kappelle L.J., Biessels G.J., Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition, Biochem. Biophys. Acta, 2009, 1792, 470-481
92. Crichton G.E., Murphy K.J., Howe P.R., Buckley J.D., Bryan J., Dairy consumption and working memory performance in overweight and obese adults, Appetite, 2012, 59, 34-40
93. Sünram-Lea S.I., Foster J.K., Durlach P., Perez C., The effect of retrograde and anterograde glucose administration on memory performance in healthy young adults, Behav. Brain Res., 2002, 134, 505-516 (Pubitemid 34912728)
94. Siervo M., Arnold R., Wells J.C., Tagliabue A., Colantuoni A., Albanese E., et al., Intentional weight loss in overweight and obese individuals and cognitive function: a systematic review and metaanalysis, Obes. Rev., 2011, 12, 968-983
95. Joseph R.J., Alonso-Alonso M., Bond D.S., Pascual-Leone A., Blackburn G.L., The neurocognitive connection between physical activity and eating behavior, Obes. Rev., 2011, 12, 800-812
96. Takahashi H., Sassa T., Shibuya T., Kato M., Koeda M., Murai T., et al., Effects of sports participation on psychiatric symptoms and brain activations during sports observation in schizophrenia, Transl. Psychiatry, 2012, 2, e96
97. Pajonk F.G., Wobrock T., Gruber O., Scherk H., Berner D., Kaizl I., et al., Hipocampal plasticity in response to exercise in schziophrenia, Arch. Gen. Psychiatry, 2010, 67, 133-143
98. Strassnig M., Ganguli, R., Weight loss interventions for patients with schizophrenia, Clin. Schizophr. Relat. Psychoses, 2007, 1, 43-53
99. Ganguli R., Behavioral therapy for weight loss in patients with schizophrenia, J. Clin. Psychiatry, 2007, 68 (Suppl 4.), 19-25 (Pubitemid 46766508)
100. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P., A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes, Am. J. Psychiatry, 2011, 168, 472-485
101. Brekke J., The relationship between cognitive and environmental determinants of the functional dimensions in schizophrenia, NIMH-sponsored conference, Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS - CT), Bethesda, Maryland, 2007